IMVT compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

IMVTImmunovant, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IMVT: latest quarter not drawable.Method ›

Price

rebased to 0%

IMVT, solidAMGN, dashed

IMVTImmunovant, Inc.

29.83· pre 29.83· delayed

Mkt cap$6.2BRevenue—Revenue—

AMGNAmgen Inc

478.34· pre 479.89· delayed

Pre-marketNov 5 '26delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Pre-marketNov 5 '26delayed

IMVTImmunovant, Inc.

AMGNAmgen Inc

29.83pre 29.83delayed

Price

478.34pre 479.89delayed

$6.2B

Mkt cap

$258.8B

—

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

IMVT29.83vsAMGN478.34Pre-marketNov 5 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IMVT 4

ROIVRoivant Sciencessupplier

—Ypsomedunlistedsupplier

—Roivant Sciences GmbHunlistedsupplier

—HanAllunlistedsupplier

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›